{"brief_title": "A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)", "brief_summary": "The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are being treated for MAC.", "condition": ["Mycobacterium Avium-Intracellulare Infection", "HIV Infections"], "intervention_type": ["Drug"], "intervention_name": ["Nelfinavir mesylate"], "criteria": "Inclusion Criteria Patients must have: - HIV infection - New diagnosis of MAC bacteremia and < 7 days of therapy. Prior Medication: Allowed: Patients no more than 7 days of therapy for MAC disease. Exclusion Criteria Prior Medication: Excluded: Prior therapy (or less than 2 weeks) with protease inhibitors other than saquinavir.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Anti-HIV Agents", "mesh_term": ["Infection", "Communicable Diseases", "HIV Infections", "Mycobacterium Infections", "Opportunistic Infections", "Mycobacterium avium-intracellulare Infection", "Nelfinavir"], "id": "NCT00002170"}